Icodextrin to delay full-dose dialysis in first year of incremental PD
Part of Kidney & urinary clinical trials.
This study tests whether a special dialysis fluid called icodextrin can help people on a low-dose form of peritoneal dialysis stay on that low dose longer before needing a full dose. It is for adults who still make some urine and can do dialysis at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your kidney function (eGFR) is at least 3 when the study starts.
- You still make at least 500 ml (about 2 cups) of urine per day.
- You are able to learn and do home peritoneal dialysis with a helper if needed.
- You can come to the clinic for checkups every 2 months or so for at least 13 months.
- You are not allergic to icodextrin, starch, or starch products, and do not have glycogen storage disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how much of a dialysis fluid called icodextrin stays in your body after one or two doses. It is for people on long-term peritoneal dialysis who are stable and can follow a specific daily schedule.
This study tests a special dialysis fluid made with amino acids (protein building blocks) instead of the usual sugar-based fluid. It may help control blood sugar and improve nutrition in people with diabetes on peritoneal dialysis.
This study tests how well a continuous glucose monitor (CGM) works in people with diabetes who are also using a special dialysis fluid called icodextrin. The goal is to see if the CGM gives accurate readings while on this treatment.
This trial tests whether empagliflozin, a medication originally for diabetes, can help protect the remaining kidney function in people who have just started peritoneal dialysis. If you started dialysis within the last 3 months and still make some urine, this study may be a good fit.
This study uses a continuous glucose monitor to track blood sugar levels in people with diabetes who are on peritoneal dialysis. It may help improve diabetes management during dialysis.
This trial studies a type of peritoneal dialysis using a special fluid called icodextrin once a day. It may help people who still make a good amount of urine to remove extra fluid more easily.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.